[The vaso-active intestinal polypeptide in Verner-Morrison syndrome].
A 40-year-old man with the Verner-Morrison syndrome (refractory watery diarrhoea and hypokalaemia in islet-cell tumour of the pancreas) had an islet-cell carcinoma of the non-B-cell type with metastases to liver and mesenteric lymph nodes.  High concentrations of a vasoactive intestinal polypeptide (VIP) were demonstrated in tumour tissue and plasma by radioimmunological tests.  After surgical removal of the tumour the plasma VIP concentration fell to normal.  Immunohistochemical tests of the tumour for gastrointestinal hormones demonstrated marked fluorescence only for vaso-active intestinal polypeptide.  It is assumed that this polypeptide is largely responsible for the clinical signs.  In the described case the severe watery diarrhoea ceased after glucocorticoid administration.
D058186:Acute Kidney Injury / Q000188:drug therapy / Q000378:metabolism; D007516:Adenoma, Islet Cell / Q000188:drug therapy / Q000378:metabolism*; D000328:Adult; D003681:Dehydration / Q000188:drug therapy / Q000378:metabolism*; D005455:Fluorescent Antibody Technique; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008113:Liver Neoplasms / Q000378:metabolism; D008207:Lymphatic Metastasis; D008297:Male; D008643:Mesentery; D009362:Neoplasm Metastasis; D010190:Pancreatic Neoplasms / Q000378:metabolism; D010455:Peptides / Q000097:blood / Q000494:pharmacology; D011863:Radioimmunoassay; D013577:Syndrome
D005938:Glucocorticoids; D010455:Peptides
Das vasoaktive intestinale Polypeptid beim Verner-Morrison-Syndrom